If you have trouble reading this newsletter, view the web version here

   

Advance IVF Globally: Submit to JIVFww - Reach 100K+ Experts!

The Journal of IVF-Worldwide (JIVFww)

The new open-access journal for advancing in vitro fertilization globally

A new article is just being published

Increased gonadotropin dosing (375 vs 225 IU/day) does not improve clinical outcomes in poor-prognosis patients undergoing IVF: results of a multi-center randomized controlled trial

Kovacs P, Nagy DU, Boga P, Zadori J, Sandfeld E, Lindheim SR.


Journal of IVF-Worldwide: 2025;3(4):1-13. doi:10.46989/​001c.143551

More Medication Isn't Always Better: Rethinking Gonadotropin Dosing for Poor Responders: For years, fertility specialists have relied on a simple equation: struggling ovaries need higher hormone doses. But does this conventional wisdom actually work? A prospective, randomized controlled trial across six Hungarian fertility centers investigated whether elevated gonadotropin protocols truly benefit poor responder patients. Researchers compared standard versus high-dose stimulation strategies in nearly 200 women with low ovarian reserve, measuring clinical pregnancy, live birth, and cumulative success rates. The results challenge long-held assumptions about optimal dosing strategies. Discover what the data reveals about balancing treatment intensity with real-world outcomes, and what it means for your patients and practice.

For the full article

JIVFww invites your contribution.
Help us push the boundaries of knowledge, transform patient care, and achieve reproductive success for individuals and couples worldwide.
Your participation is warmly welcomed!


Warm regards,

Zeev Shoham Milton Leong


Click here to read more

contact@ivf-worldwide.com


If you prefer not to receive future email communications from us, please unsubscribe here

This newsletter was sent using ITnewsletter